Comparing Caplyta vs Valium
Caplyta (lumateperone) | Valium (diazepam) |
|
---|
Caplyta (lumateperone) | Valium (diazepam) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Caplyta is an atypical antipsychotic that is used to treat adults with schizophrenia or depression associated with bipolar disorder. Sleepiness is the most common side effect and it should not be... View more |
Prescription only
Valium may be used occasionally to relieve anxiety and some other conditions such as acute muscle spasms and alcohol withdrawal. However, it is addictive and withdrawal symptoms can be severe... View more |
||||||||
More about Caplyta (lumateperone) | More about Valium (diazepam) | ||||||||
Ratings & Reviews | |||||||||
Caplyta has an average rating of 6.6 out of 10 from a total of 184 ratings on Drugs.com. 55% of reviewers reported a positive effect, while 29% reported a negative effect. |
Valium has an average rating of 8.6 out of 10 from a total of 342 ratings on Drugs.com. 85% of reviewers reported a positive effect, while 8% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Caplyta side effects |
View all Valium side effects |
||||||||
Drug Class | |||||||||
Generic Availability | |||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
View all Caplyta prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms | |||||||||
|
|
||||||||
Brand Names | |||||||||
N/A |
Other diazepam brands include: Diastat, Diastat AcuDial, Diastat Pediatric, Diazepam Intensol, Libervant, Valtoco | ||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
18 hours |
70 hours |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Some potential for abuse
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
||||||||
Pregnancy Category | |||||||||
Summary unavailable. See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 605 drugs are known to interact with Caplyta:
|
A total of 525 drugs are known to interact with Valium:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
|
|||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
December 20, 2019 |
November 15, 1963 |
||||||||
WADA Class View classifications | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient Resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.